D. Western Therapeutics Institute, Inc. (TYO:4576)
Japan
· Delayed Price · Currency is JPY 117.00
+2.00 (1.71%)
May 20, 2025, 3:30 PM JST
TYO:4576 Revenue
In the year 2024, D. Western Therapeutics Institute had annual revenue of 471.00M JPY with 10.05% growth. D. Western Therapeutics Institute had revenue of 122.09M in the quarter ending December 31, 2024, with 6.16% growth.
Revenue
471.00M
Revenue Growth
+10.05%
P/S Ratio
11.25
Revenue / Employee
22.43M
Employees
21
Market Cap
5.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 471.00M | 43.00M | 10.05% |
| Dec 31, 2023 | 428.00M | -20.00M | -4.46% |
| Dec 31, 2022 | 448.00M | 34.00M | 8.21% |
| Dec 31, 2021 | 414.00M | 59.00M | 16.62% |
| Dec 31, 2020 | 355.00M | -225.00M | -38.79% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |